Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PFIZER, INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Pfizer : Morgan Stanley Adjusts Price Target on Pfizer to $48 From $45, Maintains Equal-Weight Rating

10/12/2021 | 09:43am EST


ę MT Newswires 2021
All news about PFIZER, INC.
04:11pWall St ends lower as taper acceleration worries pile onto virus angst
RE
02:30pPharmaceutical Names to See Increased Volatility into Year End Amid Omicron Updates, Op..
MT
01:37pEquities Drop Midday as Moderna CEO Questions COVID-19 Vaccines' Efficacy Against Omicr..
MT
01:26pMIDDAY REPORT : US Stocks Drop as Moderna CEO Questions COVID-19 Vaccines' Efficacy Agains..
MT
11:58aBioNTech CEO says vaccine likely to protect against severe COVID from Omicron
RE
11:20aU.S. FDA panel weighs Merck's COVID-19 antiviral drug
RE
10:43aGLOBAL MARKETS LIVE : Amazon, Microsoft, Volvo, Glencore, Regeneron...
09:33aPfizer, NiKang Therapeutics to Study Combination Therapies to Treat Kidney Cancer
MT
09:32aThinking about trading options or stock in Vir Biotechnology, Novavax, Applied Material..
PR
09:23aGSK Brings In Pfizer Executive As New Head Of Vaccines R&D Unit
MT
More news
Analyst Recommendations on PFIZER, INC.
More recommendations
Financials (USD)
Sales 2021 81 517 M - -
Net income 2021 21 354 M - -
Net Debt 2021 27 873 M - -
P/E ratio 2021 13,5x
Yield 2021 3,01%
Capitalization 294 B 294 B -
EV / Sales 2021 3,95x
EV / Sales 2022 3,71x
Nbr of Employees 78 500
Free-Float 59,3%
Chart PFIZER, INC.
Duration : Period :
Pfizer, Inc. Technical Analysis Chart | PFE | US7170811035 | MarketScreener
Technical analysis trends PFIZER, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Last Close Price 52,40 $
Average target price 49,58 $
Spread / Average Target -5,39%
EPS Revisions
Managers and Directors
Albert Bourla Chairman, Chief Executive & Operating Officer
Susan Silbermann President & General Manager-Pfizer Vaccines
Frank A. D'Amelio Chief Financial Officer & EVP-Global Supply
Mikael Dolsten Chief Scientific Officer & Research President
Lidia L. Fonseca Executive VP, Chief Digital & Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
PFIZER, INC.42.35%294 114
JOHNSON & JOHNSON1.16%420 557
ROCHE HOLDING AG15.70%334 662
NOVO NORDISK A/S67.75%247 392
ELI LILLY AND COMPANY50.93%231 027
ABBVIE INC.9.09%206 648